1NCE and Pessl Instruments Connect Smart Farms Worldwide

1NCE, a company offering a plug-and-play platform for creating and managing the world’s best IoT products, and Pessl Instruments, a global leader in smart agriculture, announce today the roll-out of theMETOS by Pessl Instrumentsweather network solution powered by 1NCE. The smart farming solution provided by Pessl Instruments connects thousands of weather stations and field sensors through a single platform, providing farmers real-time data of precipitation and...
Anglais

FlexGen’s HybridOS Energy Management System Receives ISO 9001:2015 Certification, Strengthening Its Platform to Serve International Markets

FlexGen Power Systems, LLC.(“FlexGen”), a leading battery energy storage system and energy management software provider, today announced that its HybridOS energy management platform is ISO 9001:2015 certified. ISO 9001:2015 is an internationally recognized standard for quality management, meaning the systems and processes behind HybridOS, from design, development, deployment...
Anglais

Xpress Genomics Joins Parse Biosciences’ Certified Service Provider Network

Parse Biosciences,the leading provider of scalable and accessible single cell sequencing, and a QIAGEN company, today announced thatXpress Genomicshas joined its Certified Service Provider (CSP) program, becoming the first in the Nordic region. The Stockholm-based company will offer Parse's Evercode single cell sequencing...
Anglais

Copeland Enters into Exclusive Negotiations to Acquire Dickson, Advancing Cold Chain Leadership

Copeland, a global leader in compression technologies and controls solutions, today announced its entry into exclusive negotiations towards the purchase of Dickson, a portfolio company of May River Capital and provider of environmental monitoring and cloud-native software...
Anglais

Opzelura® (ruxolitinib) Cream Becomes First Steroid-Free Topical JAK Inhibitor Approved in the European Union for Adults with Moderate Atopic Dermatitis

Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Opzelura®(ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids (TCSs) and topical...
Anglais